Blogs
Stay informed with the latest updates and developments from BDR.
Featured Articles
DNA
BDR Compulsory Licensing
Globally harmonised patenting laws recognise the sovereignty of nations like India which retain the right to compulsory licensing. This is in case the patent holder does not manufacture sufficient quantity
Business World
Lording Over The World Of Generics
With around 30 per cent marketshare, Cancidas (generic name caspofungin), the global blockbuster antifungal made by US based pharmaceutical multinational Merck, has a sizeable presence in India.
BDR Compulsory Licensing
Globally harmonised patenting laws recognise the sovereignty of nations like India which retain the right to compulsory licensing. This is in case the patent holder does not manufacture sufficient quantity
Read More
Lording Over The World Of Generics
With around 30 per cent marketshare, Cancidas (generic name caspofungin), the global blockbuster antifungal made by US based pharmaceutical multinational Merck, has a sizeable presence in India.
Read More
Fair Treatment: Dharmesh Shah, Chairman & Managing Director of BDR Pharmaceuticals International Pvt Ltd
It was a chance meeting with the parents of a critically ill boy that motivated Dharmesh Shah to change the lives of thousands of cancer sufferers. It wasn’t the first time the chairman and md of BDR Pharma had focused on helping others.
Read More